Chemoinformaics analysis of 3,4-Dihydrocoumarin
| Molecular Weight | 148.161 | nRot | 0 |
| Heavy Atom Molecular Weight | 140.097 | nRig | 10 |
| Exact Molecular Weight | 148.052 | nRing | 2 |
| Solubility: LogS | -5.573 | nHRing | 1 |
| Solubility: LogP | 5.288 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 21.9683 |
| nHD | 0 | BPOL | 10.6297 |
| QED | 0.583 |
| Synth | 4.773 |
| Natural Product Likeliness | 3.451 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.124 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.466 |
| MDCK | 0.0000131 |
| BBB | 0.906 |
| PPB | 0.96066 |
| VDSS | 2.199 |
| FU | 0.0397977 |
| CYP1A2-inh | 0.604 |
| CYP1A2-sub | 0.48 |
| CYP2c19-inh | 0.31 |
| CYP2c19-sub | 0.845 |
| CYP2c9-inh | 0.312 |
| CYP2c9-sub | 0.626 |
| CYP2d6-inh | 0.021 |
| CYP2d6-sub | 0.701 |
| CYP3a4-inh | 0.16 |
| CYP3a4-sub | 0.243 |
| CL | 16.946 |
| T12 | 0.063 |
| hERG | 0.017 |
| Ames | 0.008 |
| ROA | 0.025 |
| SkinSen | 0.181 |
| Carcinogencity | 0.087 |
| EI | 0.938 |
| Respiratory | 0.37 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.858512 |